×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RNAC – cartesian therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RNAC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
09:09 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is now covered by analysts at BTIG Research. They set a "buy" rating and a $42.00 price target on the stock.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is now covered by analysts at BTIG Research. They set a "buy" rating and a $42.00 price target on the stock.
12/18
07:05 am
rnac
Cartesian Therapeutics Announces New Employment Inducement Grants
High
Report
Cartesian Therapeutics Announces New Employment Inducement Grants
12/16
08:07 am
rnac
Arthrosi Appoints John Leaman, M.D., to Its Board of Directors [Yahoo! Finance]
Low
Report
Arthrosi Appoints John Leaman, M.D., to Its Board of Directors [Yahoo! Finance]
12/4
08:09 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock, up previously from $41.00.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock, up previously from $41.00.
12/3
09:03 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
Medium
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
12/3
08:02 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.
Low
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.
12/3
06:10 am
rnac
Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial [Yahoo! Finance]
Low
Report
Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial [Yahoo! Finance]
12/3
06:00 am
rnac
Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial
Low
Report
Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial
Date
Time
Symbol
Company Name
Action
%Chg
5/8/2024
07:00 am
rnac
cartesian therapeutics, inc.
MISS
Report
1.1%
cartesian therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/13
04:17 pm
rnac
Form S-3 Cartesian Therapeutics,
Low
Report
Form S-3 Cartesian Therapeutics,
12/13
04:12 pm
rnac
Form S-3 Cartesian Therapeutics,
Low
Report
Form S-3 Cartesian Therapeutics,
12/13
04:07 pm
rnac
Form S-3 Cartesian Therapeutics,
Low
Report
Form S-3 Cartesian Therapeutics,
12/11
04:29 pm
rnac
Form 4 Cartesian Therapeutics, For: Dec 09 Filed by: Kurtoglu Metin
High
Report
Form 4 Cartesian Therapeutics, For: Dec 09 Filed by: Kurtoglu Metin
12/10
04:21 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Medium
Report
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
12/9
04:36 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Medium
Report
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
12/3
06:04 am
rnac
Form 8-K Cartesian Therapeutics, For: Dec 03
Low
Report
Form 8-K Cartesian Therapeutics, For: Dec 03
11/21
06:53 pm
rnac
Form 4 Cartesian Therapeutics, For: Nov 19 Filed by: Kurtoglu Metin
High
Report
Form 4 Cartesian Therapeutics, For: Nov 19 Filed by: Kurtoglu Metin
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: